1
0
0
(1 - 16 von 21
)
Xing: Günter Fingerle-Rowson - Medical Director
WebGünter Fingerle-Rowson Basis Ganzes Profil ansehen Angestellt, Medical Director, Hoffmann LaRoche Basel, …
Combination therapy with the type II anti-CD20 antibody ...Taylor & Francis Online
www.tandfonline.com
von C Klein · · Zitiert von: 8 — Günter Fingerle-RowsonPharma Development Clinical Oncology, F. Hoffmann-La Roche Ltd, Basel, SwitzerlandView further author information. Pages von C Klein · · Zitiert von: 8 — Günter Fingerle-RowsonPharma Development Clinical Oncology, F. Hoffmann-La Roche Ltd, Basel, SwitzerlandView further author information. Pages
Prof. Dr. Marek Trneny - EHA LibraryEHA Library
library.ehaweb.org
— Günter Fingerle-Rowson. ,. Günter Fingerle-Rowson. Affiliations: F. Hoffmann-La Roche Ltd,Basel,Switzerland. Elisabeth Wassner-Fritsch — Günter Fingerle-Rowson. ,. Günter Fingerle-Rowson. Affiliations: F. Hoffmann-La Roche Ltd,Basel,Switzerland. Elisabeth Wassner-Fritsch.
American Journal of Hematology | Blood Research JournalWiley Online Library
onlinelibrary.wiley.com
von O Al‐Sawaf · · Zitiert von: 7 — ... Günter Fingerle-Rowson,. Günter Fingerle-Rowson. F. Hoffmann-La Roche, Basel, Switzerland. Search for more papers by this author · Stephan ... von O Al‐Sawaf · · Zitiert von: 7 — ... Günter Fingerle-Rowson,. Günter Fingerle-Rowson. F. Hoffmann-La Roche, Basel, Switzerland. Search for more papers by this author · Stephan ...
Obinutuzumab or Rituximab Plus Cyclophosphamide, ...Swiss Open Access Repository
sonar.ch
von U Vitolo · · Zitiert von: 420 — Oestergaard, Günter Fingerle-Rowson, Olivier Catalani, and Tina Nielsen, F. Hoffman-La Roche, Basel, Switzerland; and Michael Wenger ... von U Vitolo · · Zitiert von: 420 — Oestergaard, Günter Fingerle-Rowson, Olivier Catalani, and Tina Nielsen, F. Hoffman-La Roche, Basel, Switzerland; and Michael Wenger ...
Discovery and Development of Obinutuzumab (GAZYVA ...Wiley Online Library
onlinelibrary.wiley.com
von C Klein · · Zitiert von: 1 — Günter Fingerle-Rowson,. Günter Fingerle-Rowson. Pharma Development Oncology, F. Hoffmann-La Roche, Basel, Switzerland. Search for more papers ... von C Klein · · Zitiert von: 1 — Günter Fingerle-Rowson,. Günter Fingerle-Rowson. Pharma Development Oncology, F. Hoffmann-La Roche, Basel, Switzerland. Search for more papers ...
Pharmacokinetics, exposure, efficacy and safety of ...John Wiley
bpspubs.onlinelibrary.wiley.com
von E Gibiansky · · Zitiert von: 4 — Günter Fingerle-Rowson,. Günter Fingerle-Rowson. Pharma Development Clinical Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
A Review of Obinutuzumab (GA101), a Novel Type II Anti- ...Springer
link.springer.com
von K Tobinai · · Zitiert von: 168 — Günter Fingerle-Rowson is an employee at F. Hoffmann-La Roche Ltd. and owns stock in F. Hoffmann-La Roche Ltd. Compliance with Ethics ... von K Tobinai · · Zitiert von: 168 — Günter Fingerle-Rowson is an employee at F. Hoffmann-La Roche Ltd. and owns stock in F. Hoffmann-La Roche Ltd. Compliance with Ethics ...
MRD response in relapsed/refractory FL after ...Nature Journal
www.nature.com
von C Pott · · Zitiert von: 19 — Nathalie Spielewoy, Guenter Fingerle-Rowson, Kirsten Mundt & Elisabeth Wassner-Fritsch. Roche, Welwyn Garden City, UK. Chris Harbron.
Guenter Fingerle-RowsonLinkos.cz
www.linkos.cz
Guenter Fingerle-Rowson. Pharma Development, F. Hoffmann-La Roche Ltd. ( Basel, Switzerland). Odborné práce publikované na Linkos.cz. Přehled odborných textů ... Guenter Fingerle-Rowson. Pharma Development, F. Hoffmann-La Roche Ltd. ( Basel, Switzerland). Odborné práce publikované na Linkos.cz. Přehled odborných textů ...
"MRD response in relapsed/refractory FL after ...Digital Commons@Becker
digitalcommons.wustl.edu
von C Pott · · Zitiert von: 29 — ... Guenter Fingerle-Rowson, F. Hoffmann-La Roche Ltd · Chris Harbron, Roche · Kirsten Mundt, F. Hoffmann-La Roche Ltd · Elisabeth Wassner-Fritsch, ... von C Pott · · Zitiert von: 29 — ... Guenter Fingerle-Rowson, F. Hoffmann-La Roche Ltd · Chris Harbron, Roche · Kirsten Mundt, F. Hoffmann-La Roche Ltd · Elisabeth Wassner-Fritsch, ...
A model for predicting effect of treatment on progression-free ...ashpublications.org
ashpublications.org
Günter Fingerle-Rowson,. Günter Fingerle-Rowson. 2F. Hoffmann-La Roche Ltd, Basel, Switzerland;. Search for other works by this author on: This Site · PubMed. Günter Fingerle-Rowson,. Günter Fingerle-Rowson. 2F. Hoffmann-La Roche Ltd, Basel, Switzerland;. Search for other works by this author on: This Site · PubMed.
Influence of Chemotherapy on Efficacy and SafetyASCO Publications
ascopubs.org
Günter Fingerle-Rowson. Employment: Roche. Stock or Other Ownership: Roche. Marcel Wolbers. Employment: Roche. Consulting or Advisory Role: Roche. Tina Nielsen. Günter Fingerle-Rowson. Employment: Roche. Stock or Other Ownership: Roche. Marcel Wolbers. Employment: Roche. Consulting or Advisory Role: Roche. Tina Nielsen.
Overall Survival Benefit in Patients With Rituximab- ...ASCO Publications
ascopubs.org
Lugtenburg, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; and Günter Fingerle-Rowson, Federico Mattiello, and Andrea Knapp, F. Hoffmann-La Roche, ... Lugtenburg, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; and Günter Fingerle-Rowson, Federico Mattiello, and Andrea Knapp, F. Hoffmann-La Roche, ...
Randomized Phase II Trial Comparing Obinutuzumab ...Europe PMC
europepmc.org
von LH Sehn · · Zitiert von: 179 — ... Günter Fingerle-Rowson, Roche, Basel, Switzerland; Akiko Chai, Genentech BioOncology, South San Francisco, CA; Oliver Press, Fred Hutchinson Cancer Research ... von LH Sehn · · Zitiert von: 179 — ... Günter Fingerle-Rowson, Roche, Basel, Switzerland; Akiko Chai, Genentech BioOncology, South San Francisco, CA; Oliver Press, Fred Hutchinson Cancer Research ...
Risk of HBV reactivation in patients with B-cell lymphomas ...Europe PMC
europepmc.org
von S Kusumoto · · Zitiert von: 113 — ... Günter Fingerle-Rowson. 13Product Development Oncology, F. Hoffmann-La Roche Ltd., Basel, Switzerland; and. Find articles by Günter Fingerle-Rowson. Tina ... von S Kusumoto · · Zitiert von: 113 — ... Günter Fingerle-Rowson. 13Product Development Oncology, F. Hoffmann-La Roche Ltd., Basel, Switzerland; and. Find articles by Günter Fingerle-Rowson. Tina ...
Alle Infos zum Namen "Günter Fingerle-Rowson"
Verwandte Suchanfragen zu Günter Fingerle-Rowson
| Marcel Wolbers Andreas Meinhardt Kirsten Fischer | Philipp Lacher Clemens-Martin Wendtner Dominik Schumacher | Jörg Klug Suada Fröhlich Kaspar Rufibach |
Personen Vorname "Günter" (29119) Name |
sortiert nach Relevanz / Datum